Table 1 Clinicopathological features of iCCA patients
From: HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Variables | |
|---|---|
No. of patients | 72 |
Male | 47 |
Female | 25 |
Age (years) | |
< 60 | 23 |
≥ 60 | 49 |
Etiology | |
HBV | 14 |
HCV | 10 |
Hepatolithiasis | 5 |
PSC | 3 |
NA | 40 |
Liver cirrhosis | |
Yes | 21 |
No | 51 |
Tumor differentiation | |
Well | 35 |
Moderately | 20 |
Poorly | 17 |
Tumor size (cm) | |
< 5 | 53 |
> 5 | 19 |
Tumor number | |
Single | 58 |
Multiple | 14 |
Prognosis | |
Better (≥ 3 years) | 25 |
Poorer (< 3 years) | 47 |
Lymph node metastasis | |
Yes | 24 |
No | 48 |
Lung metastasis | |
Yes | 15 |
No | 57 |